These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Separation of pure toxic peptides from a beta-gliadin subfraction using high-performance liquid chromatography.
    Author: Jos J, de Tand MF, Arnaud-Battandier F, Boissel JP, Popineau Y, Wajcman H.
    Journal: Clin Chim Acta; 1983 Oct 31; 134(1-2):189-98. PubMed ID: 6652909.
    Abstract:
    The beta v subfraction was isolated from peptic-tryptic digests of beta-gliadin by chromatography on Biogel P-10 and applied to a Lichrosorb RP-18 or a mu-Bondapak C-18 column. Fractionation was achieved using reverse-phase high-performance liquid chromatography with a linear gradient of acetonitrile in ammonium acetate. A better resolution was obtained with the mu-Bondapak column. The first-eluted peptides a, b and c1 appeared to be well purified and apparently uncontaminated. Analysis of peptides a and b showed that they contained 40 to 42% glutamine/glutamic acid, 20 to 23% proline, 14 to 16% valine and 8 to 10% leucine. They had valine as the N-terminal amino acid and their molecular mass was estimated as 5500 using sodium dodecylsulfate electrophoresis after dansylation. Peptide c1 differed from peptides a and b in containing less valine and leucine and additional amino acids such as threonine, phenylalanine and tyrosine. In addition, it had a lower molecular mass (approximately 5000) and serine as the N-terminal amino acid. Peptide b exhibited an obvious cytotoxicity for cultured coeliac jejunal mucosa at a very low concentration (0.01 g/l) and was the most toxic peptide.
    [Abstract] [Full Text] [Related] [New Search]